Status:

UNKNOWN

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Lead Sponsor:

Eastern Hepatobiliary Surgery Hospital

Conditions:

Hepatocellular Carcinoma With CSPH

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The aim of this study is to compare the operative complication and short-/long-term therapeutic effects of percutaneous local ablative therapy (PLAT) versus surgical resection(SR) on small hepatocellu...

Detailed Description

HCC is a major health problem worldwide, with an estimated incidence ranging between 500,000 and 1,000,000 new cases annually. It is the fifth most common cancer in the world and the third most common...

Eligibility Criteria

Inclusion

  • 18 Years \< ge ≤ 70 Y,KPS ≥ 70
  • A solitary HCC ≤ 5cm in diameter,or multiple HCC(≤3) ,each ≤3cm in diameter without evidence of radiologically definable vascular invasion or extrahepatic metastasis. allowing to both SR and PLAT
  • Child-Pugh class A or B,without history of encephalopathy,ascites refractory to diuretics,or variceal bleeding
  • NO previous treatment of HCC
  • Platelet count\>40,000/mm3;prothrombin time prolongation of no more than 3 seconds
  • Patients who can understand this trial and have signed information consent

Exclusion

  • metastatic liver cancer
  • Patients with apparent cardiac,pulmonary,cerebral and renal dysfunction,which may affect the treatment of HCC
  • 3\) Patients with other diseases which may affect the treatment mentioned
  • 4) Patients participating in other clinical trials
  • 5) Patients with a medical history of other malignant tumors
  • 6\) Pregnant and breast-feeding women

Key Trial Info

Start Date :

January 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01860222

Start Date

January 1 2011

End Date

December 1 2016

Last Update

March 31 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Eastern Hepatobiliary Surgery Hospital

Shanghai, China

2

Eastern Hepatobiliary Surgery Hospital

Shanghai, China